References
Sadiq SA, Poopatana CA (2007) Intrathecal baclofen and morphine in multiple sclerosis patients with severe pain and spasticity. J Neurol 254:1464–1465. doi:10.1007/s00415-007-0566-z
Sadiq SA (2005) Management of spasticity. In: Younger D (ed) Motor disorders, 2nd edn. Lippincott Williams and Wilkins, Philadelphia, pp 689–698
Erwin A, Gudesblatt M, Bethoux F, Bennett SE, Koelbel S, Plunkett R, Sadiq S, Stevenson VL, Thomas AM, Tornatore C, Zaffaroni M, Hughes M (2011) Intrathecal baclofen in multiple sclerosis: Too little, too late? Mult Scler 17(5):623–629. doi:10.1177/1352458510395056
Sadiq SA, Wang GC (2006) Long-term intrathecal baclofen therapy in ambulatory patients with spasticity. J Neurol 253:563–569. doi:10.1007/s00415-005-0060-4
Cooper JA, Ridley B (2006) Response of intrathecal baclofen resistance to dose reduction. Neurology 67(8):1495–1496. doi:10.1212/01.wnl.0000240223.01418.2e
Eisenach JC, De Kock M, Klimscha W (1996) Alpha(2)-adrenergic agonists for regional anaesthesia. A clinical review of clonidine (1984–1995). Anesthesiology 85:655–674. doi:10.1097/00000542-199609000-00026
Middleton JW, Siddall PJ, Walker S, Molloy AR, Rutkowski SB (1996) Intrathecal clonidine and baclofen in the management of spasticity and neuropathic pain following spinal cord injury: a case study. Arch Phys Med Rehabil 77:824–826. doi:10.1016/S0003-9993(96)90264-6
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ho, J.K., Sadiq, S.A. Use of intrathecal clonidine in patients with multiple sclerosis or spastic paraparesis. J Neurol 259, 982–984 (2012). https://doi.org/10.1007/s00415-011-6290-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-011-6290-8